Targeted diagnostics of breast cancer based on a comprehensive analysis of risk factors

Alexander Lazarev
{"title":"Targeted diagnostics of breast cancer based on a comprehensive analysis of risk factors","authors":"Alexander Lazarev","doi":"10.17816/onco624299","DOIUrl":null,"url":null,"abstract":"Research objective was to improve the quality and efficiency of diagnostic measures for breast cancer through a personalized approach to patients based on an analysis of a set of risk factors. The methodology was developed using the data from the population-based Cancer Registry of the Altai Territory, created at the Altai Regional Oncology Center in Barnaul, Russia. At the moment the Cancer Registry included information on 308,550 patients with malignant neoplasms, including 31,783 women with breast cancer. On the basis of the method of breast cancer risk assessment proposed by Lazarev A.F. (patent number: RU 2651131 C1) an automated program for early diagnosis of breast cancer has been developed (state registration certificate for computer program No. 2019661203). The program significantly reduces the time for risk assessment and allows to form groups of high breast cancer risk, increases the efficiency of breast cancer diagnostics, and serves as a basis for development of set of targeted preventive measures specific for each patient. Testing of this technique included assessment of 512 patients, which resulted in forming of a high-risk precancer group of patients having individual risk of developing breast cancer either increased or high or absolute. 92 patients were determined to belong to the high risk pre-cancer group. The patients had a complex of in-depth examinations (including ultrasound, mammography, MRI with dynamic contrast and breast biopsy if indicated). 7 of 92 patients (7.6%) were diagnosed with breast cancer, all at early stages (I or II). It allows to suggest implementation of the method with the aim to assign in-depth examination in more targeted manner to patients at high risk of breast cancer and to contribute to detection the cancer in the early stages.","PeriodicalId":509207,"journal":{"name":"Russian Journal of Oncology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Russian Journal of Oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17816/onco624299","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Research objective was to improve the quality and efficiency of diagnostic measures for breast cancer through a personalized approach to patients based on an analysis of a set of risk factors. The methodology was developed using the data from the population-based Cancer Registry of the Altai Territory, created at the Altai Regional Oncology Center in Barnaul, Russia. At the moment the Cancer Registry included information on 308,550 patients with malignant neoplasms, including 31,783 women with breast cancer. On the basis of the method of breast cancer risk assessment proposed by Lazarev A.F. (patent number: RU 2651131 C1) an automated program for early diagnosis of breast cancer has been developed (state registration certificate for computer program No. 2019661203). The program significantly reduces the time for risk assessment and allows to form groups of high breast cancer risk, increases the efficiency of breast cancer diagnostics, and serves as a basis for development of set of targeted preventive measures specific for each patient. Testing of this technique included assessment of 512 patients, which resulted in forming of a high-risk precancer group of patients having individual risk of developing breast cancer either increased or high or absolute. 92 patients were determined to belong to the high risk pre-cancer group. The patients had a complex of in-depth examinations (including ultrasound, mammography, MRI with dynamic contrast and breast biopsy if indicated). 7 of 92 patients (7.6%) were diagnosed with breast cancer, all at early stages (I or II). It allows to suggest implementation of the method with the aim to assign in-depth examination in more targeted manner to patients at high risk of breast cancer and to contribute to detection the cancer in the early stages.
基于风险因素综合分析的乳腺癌靶向诊断
研究目标是在分析一系列风险因素的基础上,通过对患者采取个性化方法,提高乳腺癌诊断措施的质量和效率。 该方法是利用俄罗斯巴尔瑙尔阿尔泰地区肿瘤中心建立的阿尔泰边疆区人口癌症登记处的数据开发的。目前,该癌症登记处包括 308550 名恶性肿瘤患者的信息,其中包括 31783 名乳腺癌女性患者。在拉扎列夫-A.F.提出的乳腺癌风险评估方法(专利号:RU 2651131 C1)的基础上,开发了乳腺癌早期诊断自动程序(计算机程序国家注册证书编号:2019661203)。该程序大大缩短了风险评估的时间,并可形成乳腺癌高危人群,提高乳腺癌诊断的效率,并为针对每位患者制定一套有针对性的预防措施奠定基础。对该技术的测试包括对 512 名患者进行评估,评估结果显示,这些患者患乳腺癌的个人风险或增加或增加,或绝对增加。92 名患者被确定为属于高风险癌前病变组。这些患者接受了一系列深入检查(包括超声波、乳腺 X 射线照相术、动态对比 MRI 和乳腺活组织检查(如有必要))。92 名患者中有 7 人(7.6%)被确诊为乳腺癌,且均处于早期阶段(I 期或 II 期)。因此,建议采用这种方法,以便更有针对性地对乳腺癌高危患者进行深入检查,从而有助于在早期阶段发现癌症。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信